FDA Continues Its March To Inoculate Children With Experimental COVID-19 “Vaccines”.

On April 29, US drug authorities hinted that COVID-19 vaccinations for young children might be approved in June. The FDA has announced that its expert advisory group, the Vaccines and Related Biological Products Advisory Committee (VRBPAC), will meet to discuss revisions to the Moderna and Pfizer emergency use authorizations (EUAs). Pfizer is still waiting on clinical trial data after its two-shot primary regimen failed to trigger an adequate immune response in children aged 6 months to 4 years old. Moderna announced Thursday that it submitted an EUA for children aged 6 months to 5 years old; Pfizer is still waiting on clinical trial data after its two-shot primary regimen failed to trigger an adequate immune response in children aged 6 months to 4 years old. The sessions will be held on June 8, 21, and 22 at the FDA. In…

Read More